DurgicalDurgical
EN
Open the app

Leigh syndrome !

Leigh syndrome is a severe childhood mitochondrial disease that damages the basal ganglia and brainstem and makes children lose skills they had learned.

Updated 2026-11-01

Structures involved

Tap one to see what it is and open it in 3D.

In biochemistry

In histology

Why it happens

What it is

Subacute necrotising encephalopathy: symmetrical lesions of the basal ganglia and brainstem from failed energy production, usually starting before age 2.

Who gets it

It affects at least 1 in 40,000 newborns, with much higher rates in some isolated populations. It is the most common presentation of mitochondrial disease in childhood; there are no figures for Colombia.

Causes

  • Variants in more than 110 genes, nearly all in oxidative phosphorylation or pyruvate metabolism
  • Nuclear DNA in about 80%: complex I genes (NDUF), SURF1 (complex IV assembly), PDHA1 (pyruvate dehydrogenase), among others
  • Mitochondrial DNA in about 20%: for example MT-ATP6 (m.8993T>G) and MT-ND genes

Risk factors

  • Consanguinity (autosomal recessive forms)
  • A mother carrying a mitochondrial DNA variant
  • Decompensations triggered by infections, fever or fasting

Pathophysiology

Failure of a respiratory complex, ATP synthase or pyruvate dehydrogenase lowers the ATP that neurons and glia need; pyruvate and NADH build up and lactate appears in blood and cerebrospinal fluid. The areas with the highest energy demand (putamen, caudate nucleus, brainstem) undergo focal necrosis, gliosis and capillary proliferation, with bilateral symmetrical lesions. Brainstem damage explains the abnormal breathing rhythm and eye movements.

Symptoms and signs

  • Loss of motor and language skills already acquired (regression)
  • Hypotonia, poor sucking and swallowing, vomiting, poor weight gain
  • Ataxia, dystonia and spasticity
  • Nystagmus, strabismus, ophthalmoplegia and optic atrophy
  • Irregular breathing, apneas
  • Peripheral neuropathy and sometimes cardiomyopathy

Diagnosis

Clinical
Developmental regression with basal ganglia and brainstem signs in an infant or young child.
Tests
Lactate and pyruvate in blood and cerebrospinal fluid, amino acids and organic acids; gene panel or exome with mitochondrial DNA analysis; muscle or skin biopsy with respiratory complex assays when genetics is inconclusive.
Imaging
Brain MRI: bilateral symmetrical T2 lesions of the putamen, caudate nuclei and brainstem; spectroscopy shows a lactate peak.

Treatment

Medical
Early trial of thiamine and biotin: some Leigh-like forms (for example, SLC19A3) respond very well.
Medical
Ketogenic diet in pyruvate dehydrogenase deficiency; coenzyme Q₁₀ in defects of its synthesis.
Acute
Management of decompensations: hydration, correction of acidosis, treatment of infections and respiratory support.
Medical
Avoiding drugs toxic to mitochondria, such as valproate, and prolonged fasting.
Rehabilitation
Physiotherapy, nutritional support (sometimes gastrostomy) and palliative care as needed.

Complications

  • Respiratory failure
  • Aspiration and malnutrition
  • Epilepsy
  • Cardiomyopathy
  • Death in childhood

Prognosis

Almost always progressive; many children die in the first years from respiratory failure. Late-onset forms and treatable ones (thiamine and biotin responsive) do better.

Test yourself

Think of the answer, then tap the question to see it.

Which brain areas are damaged in Leigh syndrome?

The basal ganglia (putamen, caudate) and the brainstem, bilaterally and symmetrically.

Which complex IV assembly gene is a classic cause of Leigh syndrome?

SURF1.

Why are thiamine and biotin tried in a child with Leigh-like lesions?

Some look-alike forms, such as the SLC19A3 transporter defect, respond very well and are treatable.

About what share of Leigh syndrome cases is due to mitochondrial DNA?

About 20%; the rest come from nuclear DNA genes.

Add to my cards (4)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Leigh syndrome: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); SURF1 gene: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); MT-ATP6 gene: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Mitochondrial Diseases: MedlinePlus (MedlinePlus, US National Library of Medicine, 2026).

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.

Putamen highlighted on the Durgical 3D model